Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A Cochrane Rapid Review
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effects of pembrolizumab monotherapy versus chemotherapy for the second‐line treatment of advanced urothelial carcinoma.